UBS Group’s Avista Healthcare Public Acquisition Corp.Units AHPAU Stock Holding History

UBS Group’s Portfolio AHPAU Stock Details AHPAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10	Closed	–	–	8761
2018 Q3	$0	Hold	10	–	–	﹤0.01%	8670
2018 Q2	$0	Hold	10	–	–	﹤0.01%	8726
2018 Q1	$0	Hold	10	–	–	﹤0.01%	8635
2017 Q4	$0	Hold	10	–	–	﹤0.01%	8542
2017 Q3	$0	Hold	10	–	–	﹤0.01%	8487
2017 Q2	$0	Buy	+10	New	+$103	﹤0.01%	8490
2017 Q1	–	Sell	-1,600	Closed	-$16K	–	8519
2016 Q4	$16K	Buy	+1,600	New	+$16.1K	﹤0.01%	6672

UBS Group's AHPAU Position: Q4 2018 in Review

UBS Group sold out of Avista Healthcare Public Acquisition Corp.Units (AHPAU) in Q4 2018, closing a stake of 10 shares.

UBS Group first reported a position in AHPAU in Q4 2016 and held it in 7 quarters. The position peaked at $16K in Q4 2016. 0 funds tracked by Wall St. Rank hold AHPAU as of Q4 2018.

UBS Group reported no remaining Avista Healthcare Public Acquisition Corp.Units position as of Q4 2018 after selling out during the quarter.
UBS Group sold 10 Avista Healthcare Public Acquisition Corp.Units shares in Q4 2018.
UBS Group first reported a position in Avista Healthcare Public Acquisition Corp.Units in Q4 2016 and held it in 7 quarters.
UBS Group's Avista Healthcare Public Acquisition Corp.Units position peaked at $16K in Q4 2016.
0 funds tracked by Wall St. Rank held Avista Healthcare Public Acquisition Corp.Units as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.